NNE builds new vaccine facility for Bavarian Nordic in record time  

2005.10.06
In just 11 months, Novo Nordisk Engineering (NNE) has built a new vaccine production facility for the biopharmaceutical company Bavarian Nordic A/S

In the record-breaking time of 11 months, Novo Nordisk Engineering (NNE) has built a new vaccine production facility for the biopharmaceutical company Bavarian Nordic A/S. The new facility, based in Kvistgaard, Denmark, started production in July.

The speed of the fast-track project has been essential to Bavarian Nordic, which is participating in the US Government's programme to develop and acquire a safe smallpox vaccine based on the Modified Vaccinia Ankara (MVA) virus.

"Thanks to NNE's expedited project execution, Bavarian Nordic now has an operational vaccine facility that can produce 40 to 60 million doses of IMVAMUNET [the company's MVA smallpox vaccine] per year", says Dr. René Djurup, Executive Vice President and Chief Technical Officer of Bavarian Nordic.

The new state-of-the-art smallpox vaccine production facility includes clean rooms that are three times the size of industry standards and which also meet or exceed the US FDA and EU standards for compliance. The flexible disposable production technology also enables Bavarian Nordic to adjust the facility quickly and smoothly to produce other vaccines if required.

In 2001 NNE gave itself five years to fulfil the challenging task of becoming the first engineering company in the world capable of building pharmaceutical and biotechnological facilities in only 12 months. Its success in meeting this aim means that Bavarian Nordic has become the only company in the world able to supply the growing demand for MVA-based safe smallpox vaccines.

Link > Bavarian Nordic 

Link > NNE 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×